Wellnex Life Limited (ASX:WNX)

Market Cap	3.43M -80.7%
Revenue (ttm)	24.58M +6.3%
Net Income	-9.87M
EPS	-0.19
Shares Out	73.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	184,819
Open	0.0450
Previous Close	0.0450
Day's Range	0.0440 - 0.0470
52-Week Range	0.0440 - 0.3150
Beta	1.21
Analysts	Strong Buy
Price Target	0.44 (+836.17%)
Earnings Date	Aug 28, 2026

About Wellnex Life

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life bran...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2011
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: WNX

Financial Performance

In fiscal year 2025, Wellnex Life's revenue was 23.63 million, an increase of 40.39% compared to the previous year's 16.83 million. Losses were -15.60 million, 13.6% more than in 2024.